From the laboratory to the clinician to the patient, discover how we’re powering the moments that matter.
Did you know Beckman Coulter is a part of Danaher Diagnostics?
Together with our other operating companies, we are accelerating the real-life impact of precision diagnostics, enabling healthcare providers to diagnose diseases with unprecedented speed and precision.
Across our industry-leading operating companies and through academic and research partnerships, we’re bringing the best minds together to unlock the full potential of the latest scientific advances—accelerating innovation that will ensure precision medicine for future generations of patients.
You already know our industry-leading diagnostics businesses. Get to know Danaher.
Book appointment
Through expertise and strategic partnerships, we are pushing boundaries with next-generation technologies that improve workflow and drive confidence in patient results. From innovative biomarkers to workflow automation, here are just a few of the solutions that will be on display at ADLM.
Advantaged Workflows
Accelerate more precise clinical decision-making—from sample collection to diagnostic insight—unlocking the power of every sample and improving workflow to create new value for your laboratory teams.
Learn more
Digital Hematology
Discover how we’re delivering more insights from the CBC so you can support a higher standard of care with a growing menu of advanced biomarkers and unparalleled clinical sensitivity.
Learn more
High-Sensitivity Diagnostics
Revolutionize your core lab’s impact with unprecedented high-sensitivity diagnostic testing across diverse areas like cardiovascular disease, infectious disease, and women’s health.
Learn more
Wednesday, July 30th | 2:00pm
Presentation Description:
MDW is a hematology parameter developed by Beckman Coulter that can help identify patients with sepsis or those at an increased risk of developing sepsis within the first 12 hours of hospital admission. In this study, we present the health economic impact of implementing MDW testing for early sepsis detection in the emergency department, using real-world data from a U.S. emergency department.
Speaker Bio:
Lopamudra Das is the Director of Health Economics and Outcomes Research at Beckman Coulter. With ten years of experience in consulting and diagnostics, she has successfully led numerous Health Economics and Outcomes Research (HEOR) projects across various therapeutic areas. Lopamudra holds a PhD from the RAND Graduate School and a Master’s in Public Health from San Diego State University.
Add to CalendarWednesday, July 30th | 1:00pm
Presentation Description:
This session will address the growing global impact of Alzheimer’s disease, highlighting its epidemiology and unmet clinical needs. It will explore the disease’s pathophysiology and the role of current and emerging blood-based biomarkers in diagnosis and monitoring, with attention to assay performance. The presentation will also examine the future of biomarker development and their integration into clinical practice.
Speaker Bio:
Jean-Sébastien Blanchet is a PhD-trained immunologist with a career focused on advancing diagnostic innovation to improve patient care. After early work in DNA vaccine development at GSK, Jean-Sebastien joined Beckman Coulter, where he’s led scientific, clinical, and health economic initiatives across Europe and globally. Currently serving as the Director of Global Medical and Scientific Affairs, he’s driving evidence generation for diagnostics in neurodegenerative and infectious diseases. Jean-Sébastien serves as Beckman Coulter’s
Add to CalendarTuesday, July 29th | 2:00pm
Presentation Description:
Discover how Dr. Olga Pozdnyakova leverages DxH technology to significantly boost staff productivity and minimize manual review rates in the hematology laboratory at Penn Medicine. Through innovative applications of this cutting-edge technology, Dr. Pozdnyakova is streamlining laboratory processes, enhancing efficiency, and ensuring high-quality diagnostic outcomes.
Speaker Bio:
Dr. Olga Pozdnyakova is a distinguished specialist in hematopathology, with extensive clinical expertise in laboratory hematology, flow cytometry, and the diagnostic approach to hematologic disorders, including leukemias, lymphomas, myelomas, and mast cell disorders. After receiving an MD in Internal Medicine from Russian State Medical University and a PhD in Pediatric Hematology from the Federal Clinical Research Center in Moscow, Dr. Pozdnyakova pursued extensive postgraduate training, including residencies and fellowships at prestigious institutions such as Harvard Medical School and Brigham and Women’s Hospital. Board-certified in Anatomic and Clinical Pathology and Hematopathology by the American Board of Pathology, Dr. Pozdnyakova has made significant contributions to research, focusing on developing new testing algorithms for hematologic neoplasms and discovering novel characteristics of hematopoietic cells for diagnostic and predictive modeling. Dr. Pozdnyakova has been recognized with numerous awards, including the Excellence in Urologic Pathology Research Award and the Partners in Excellence Award, and has been an integral part of the COVID-19 response team at Brigham & Women’s Hospital. With leadership roles in several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists, Dr. Pozdnyakova continues to contribute to advancing the field through education and research. She is committed to excellence in both clinical practice and academic leadership, demonstrated by a history of directing educational courses and involvement in key committees across multiple prestigious societies.
Add to CalendarWednesday, July 30th
7:00 – 8:30 AM
McCormick Place Convention Center, Chicago – Room S105a
Join Beckman Coulter and MeMed for an exclusive breakfast symposium focused on the clinical utility and real-world application of the MeMed BV® assay.
Hear directly from leading experts as they share implementation insights and real-world data:
Dr. Alejandro Zuretti, MD
Medical Director of Laboratories, Maimonides Medical Center
Dr. Sridevi Deveraj, PhD, DABCC, FACC, FRSC, CCRP
Medical Director of Clinical Chemistry and Point of Care Testing, Texas Children’s Hospital
Dr. Edana Mann, MD, FACEP
Senior Associate Clinical Director, Department of Emergency Medicine, The Johns Hopkins Hospital
Moderated by:
Dr. Melissa Naiman, PhD, EMT-B
Medical Director, Beckman Coulter
What You’ll Learn
Why Attend?
Space is limited. Early arrival encouraged.
Add to Calendar
Catch up with these educational resources shared at ADLM 2024.
Tell us you're coming and we'll connect you with a member of the Beckman Coulter team for a tailored demo of the solutions that matter to you.
Complete the form below and we’ll reach out soon.
Thank you for your request.
A Beckman Coulter representative will contact you shortly.
English
